Junqian Xu, PhD
- ADJUNCT ASSOCIATE PROFESSOR | Diagnostic, Molecular and Interventional Radiology
Research Topics:
Brain Imaging, Diffusion Tensor Imaging, Image Analysis, Imaging, MRI, Magnetic Resonance Imaging, Multiple Sclerosis, Neuroscience, Pain, Spinal CordDr. Junqian (Gordon) Xu received his PhD degree from the Biomedical Magnetic Resonance Lab (BMRL) at Washington University in St. Louis in 2007. He completed his postdoctoral training in the Multiple Sclerosis Center at Washington University School of Medicine. In 2010, Dr. Xu joined the WU-Minn consortium of the Human Connectome Project (HCP) and had worked on multiband EPI sequence development at the Center for Magnetic Resonance Research (CMRR), University of Minnesota for two years before joining Mount Sinai in 2012 to establish a neuroimaging laboratory using advanced in vivo magnetic resonance imaging (MRI) techniques.
He is also a member of the Icahn Institute for Data Science and Genomic Technology.
Complete list of publications at PubMed; citations at Google Scholar or Scopus; and peer-review records at Publon.
Multi-Disciplinary Training Areas
Neuroscience [NEU], Pharmacology and Therapeutics Discovery [PTD]Education
BS, Peking University
PhD, Washington University in St. Louis
-
2019
Faculty Council Junior Faculty Award -
2017
Dr. Harold Golden Lamport Clinical Research Award -
2015
Richard and Susan Friedman Research Scholar Award -
2014
NARSAD Young Investigator Award -
2013
RSNA Research Scholar Award
Advanced magnetic resonance (MR) techniques in neuroimaging
- brainstem and cervical spinal cord MRI at ultra-high field.
- functional and structural assessment of the spinal cord and optic nerve.
- functional MRI of small nuclei in the brain, such as the habenula.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Xu did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.